TNF and cancer: Data supporting the potential for immunomodulators, particularly TNF inhibitors, which appear to be the most commonly tested, or oral nutritional supplements to improve physical function or ameliorate functional decline in cancer cachexia, are widely inconsistent and limited to small studies that require further validation.